avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hsfy2
|
ENSMUSG00000045336.4 | heat shock transcription factor, Y-linked 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.8 | 2.3 | GO:0002582 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.7 | 2.0 | GO:0071846 | actin filament debranching(GO:0071846) |
0.7 | 2.6 | GO:0097494 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) regulation of vesicle size(GO:0097494) |
0.6 | 1.9 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.6 | 3.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 1.5 | GO:1900135 | positive regulation of eosinophil degranulation(GO:0043311) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) positive regulation of renin secretion into blood stream(GO:1900135) positive regulation of eosinophil activation(GO:1902568) |
0.5 | 1.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.5 | 1.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.4 | 4.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 15.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.4 | 2.4 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 1.2 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.4 | 2.5 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 2.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.9 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.3 | 2.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 1.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 1.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.3 | GO:0032345 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 1.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.7 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 0.7 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 1.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 2.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 1.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 2.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.7 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 0.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 4.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 2.3 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 1.0 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.5 | GO:2000373 | CRD-mediated mRNA stabilization(GO:0070934) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.2 | 1.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 1.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 0.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:1990523 | negative regulation of SMAD protein import into nucleus(GO:0060392) endothelial cell-cell adhesion(GO:0071603) negative regulation of sensory perception of pain(GO:1904057) bone regeneration(GO:1990523) |
0.1 | 0.4 | GO:0043096 | germinal center B cell differentiation(GO:0002314) adenosine catabolic process(GO:0006154) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) purine nucleobase salvage(GO:0043096) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) purine deoxyribonucleoside metabolic process(GO:0046122) negative regulation of mucus secretion(GO:0070256) |
0.1 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 8.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.3 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 4.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.2 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 1.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 1.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.1 | 2.8 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 1.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.5 | GO:0046813 | T cell antigen processing and presentation(GO:0002457) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 1.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 1.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 4.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.6 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 4.3 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 1.1 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 1.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.6 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 2.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 1.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 1.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 1.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 1.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 1.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 1.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 3.2 | GO:0043588 | skin development(GO:0043588) |
0.0 | 1.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 1.1 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 17.9 | GO:0005818 | aster(GO:0005818) |
1.0 | 2.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.9 | 3.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 3.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 2.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 1.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 1.6 | GO:0008623 | CHRAC(GO:0008623) |
0.3 | 2.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 3.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 3.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 4.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.9 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 2.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 5.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 2.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 2.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 3.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 1.7 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 2.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 2.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 2.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 2.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 12.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 4.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 4.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 1.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.5 | 1.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.5 | 1.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.4 | 1.2 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 2.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 1.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 0.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 2.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.7 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.6 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 1.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 0.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 0.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 4.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 1.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) MutSalpha complex binding(GO:0032407) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 3.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 3.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 2.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 2.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 4.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 8.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.4 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.7 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 2.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:1902282 | ATP-activated inward rectifier potassium channel activity(GO:0015272) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.2 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 1.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 1.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 1.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 2.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 12.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 2.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 2.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 4.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 4.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 3.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 4.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 2.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 3.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 3.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |